Filter
2648
Text search:
Global
Drug
Facility
Featured
Recommendations
262
New Publications
845
Language
Document type
No document type
1590
Guidelines
366
Studies & Reports
365
Manuals
127
Strategic & Response Plan
106
Training Material
37
Fact sheets
29
Situation Updates
15
Resource Platforms
7
Infographics
3
Brochures
2
App
1
Countries / Regions
India
136
Kenya
100
Global
92
Ethiopia
83
Nigeria
75
South Africa
74
Uganda
73
Tanzania
67
Nepal
58
Malawi
58
Liberia
55
Zambia
52
Ghana
50
Sierra Leone
49
Bangladesh
42
Namibia
40
Myanmar / Burma
39
Western and Central Europe
39
Rwanda
36
Africa
31
Eastern Europe
28
Zimbabwe
26
Ukraine
26
Asia
26
Cambodia
24
Lesotho
24
Philippines
22
South–East Asia Region
18
Latin America and the Carribbean
18
Syria
16
Indonesia
15
Mozambique
15
Botswana
14
Burkina Faso
13
Congo, Democratic Republic of
13
Senegal
12
Russia
12
Cameroon
10
East and Southern Africa
10
Eswatini/ Swaziland
9
South Sudan
8
Pakistan
7
West and Central Africa
6
Middle East and North Africa
6
Laos
6
Tajikistan
6
Guinea
5
Haiti
5
Thailand
5
China
5
Sudan
5
Benin
5
Yemen
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Vietnam
5
Afghanistan
4
Germany
4
Mexico
4
Sri Lanka
4
Venezuela
4
Somalia
3
Central African Republic
3
Colombia
3
Libya
3
Palestine
3
Timor Leste/ East Timor
3
Moldova
3
Georgia
3
USA
2
Iraq
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Peru
2
Brazil
2
North Macedonia
2
El Salvador
2
Bhutan
2
Albania
2
Armenia
2
Iran
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Turkey
1
Gambia
1
Ireland
1
Switzerland
1
Serbia
1
Ecuador
1
Greece
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1212
Clinical Guidelines
224
Public Health
123
Women & Child Health
109
Key Resources
107
Capacity Building
50
Pharmacy & Technologies
34
Toolboxes
TB
328
HIV
298
AMR
149
COVID-19
117
Mental Health
92
NTDs
73
Pharmacy
71
Malaria
58
Caregiver
56
Rapid Response
42
NCDs
41
Conflict
35
Ebola & Marburg
33
Planetary Health
29
Refugee
26
Health Financing Toolbox
23
Disability
21
Global Health Education
21
2.0 Rapid Response
19
Polio
14
Cholera
11
Natural Hazards
8
Specific Hazards
6
Zika
4
Social Ethics
2
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
COVID-19 vaccine market dashboard
recommended
An interactive tool for partners, manufacturers, and countries to follow the developments of the COVID-19 vaccine market with up-to-date information.
As the designated COVAX procurement coordinator and procurement agent, UNICEF has launched the COVID-19 Vaccine Market Dashboard – an interactive
...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect
...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic eff
...
Antimicrobial resistance is a global crisis that threatens a century of progress in health and achievement of the Sustainable Development Goals. There is no time to wait. Unless the world acts urgently, antimicrobial resistance will have disastrous
...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not b
...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping lab
...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymph
...
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordin
...
This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight
...
INTRODUCTION: Health service use among the public can decline during outbreaks and had been predicted among low and middle-income countries during the COVID-19 pandemic. In March 2020, the government of the Democratic Republic of the Congo (DRC) started implementing public health measures across Kin
...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to al
...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
IN THE AMOUNT OF SDR 21.8 MILLION (US$30 MILLION EQUIVALENT) WITH AN ADDITIONAL GRANT FROM THE GLOBAL FINANCING FACILITY (GFF) IN THE AMOUNT OF US$ 10 MILLION TO THE DEMOCRATIC REPUBLIC OF CONGO FOR
...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively
...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
